# Nuwacell Biotechnologies was founded a decade ago in Hefei, Anhui province.

*biotech · news · 2026-05-20 · South China Morning Post*

## Key points

- Nuwacell Biotechnologies claims their stem cell therapy achieves 80–90% neuron conversion efficiency.
- International competitors reportedly achieve less than 25% conversion of stem cells to dopaminergic neurons.
- Nuwacell's clinical trial timeline is faster than US and Japanese teams, the company asserts.
- The company was founded by Yu Junying and Zhang Ying, both returning from leading US institutions.

**Companies:** Nuwacell Biotechnologies
**Countries:** China, United States, Japan

[Read the full story on South China Morning Post](https://www.scmp.com/news/china/science/article/3353950/china-outpacing-us-biotech-race-find-cure-parkinsons-disease)

---

Canonical: https://newsio.io/n/99535428-9041-4c0c-b370-62393a4a65b5/nuwacell-biotechnologies-was-founded-a-decade-ago-in-hefei-anhui-province-stem-c
Summarized by Newsio from South China Morning Post. https://newsio.io/how-it-works